Skip to main content

EXAGEN INC

For the period ended Dec 31, 2024. Filed Mar 11, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 11, 2025

XGN$7.10+22.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EXAGEN INC.
Date: March 11, 2025by:/s/ John Aballi
John Aballi
President and Chief Executive Officer
(Principal Executive Officer)

Power of Attorney

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints John Aballi and Jeffrey G. Black as his or her true and lawful attorneys-in-fact, and each of them, with full power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact, and either of them, or his or their substitute or substitutes may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ John AballiPresident, Chief Executive Officer and DirectorMarch 11, 2025
John Aballi(Principal Executive Officer)
/s/ Jeffrey G. BlackChief Financial Officer and Corporate SecretaryMarch 11, 2025
Jeffrey G. Black(Principal Financial and Accounting Officer)
/s/ Tina S. Nova, Ph.D.Executive Chairman of the BoardMarch 11, 2025
Tina S. Nova, Ph.D.
/s/ Ana HookerDirectorMarch 11, 2025
Ana Hooker
/s/ Scott Kahn, Ph.D.DirectorMarch 11, 2025
Scott Kahn, Ph.D.
/s/ Paul KimDirectorMarch 11, 2025
Paul Kim
/s/ Bruce C. Robertson, Ph.D.DirectorMarch 11, 2025
Bruce C. Robertson, Ph.D.
/s/ Frank StokesDirectorMarch 11, 2025
Frank Stokes
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.